New Delhi, March 25 (SocialNews.XYZ) In a significant move, India has banned export of hydroxychloroquine, an anti-Malaria drug which is believed to work as a medicine for treating Coronavirus infected patients as well.
According to a late night notification by the Ministry of Commerce and Industry, the export of medication and the composition ingredients used for its manufacturing have been banned.
"The export of Hydroxychloroquine and formulations made from Hydroxychloroquine under any ITCHS Code... is prohibited with immediate effect," the DGFT under the ministry said in the notification.
Recently, the national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive medication.
"Hydroxy-chloroquine is found to be effective against coronavirus in laboratory studies and in-vivo studies. Its use in prophylaxis is derived from the available evidence of benefit as treatment and supported by preclinical data," the advisory said.
Recently, the FDA also freed India's IPCA from import ban so that it can ship unproven COVID-19 treatments. The FDA in 2015 banned products from three IPCA manufacturing facilities.
Source: IANS
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz
This website uses cookies.
